Clinical isolates of Haemophilus influenzae resistant to a broad range of 2-deoxystreptamine aminoglycosides (2-DAM) were studied. The gene responsible for resistance could be mobilized by transformation into a 2-DAM susceptible laboratory strain of H. influenzae, enabling isogenic comparisons. The transformants had the same resistance phenotype as the parental strains. There was close linkage between 2-DAM resistance and streptomycin resistance, a chromosomal marker, but weak linkage between 2-DAM and erythromycin resistance. Resistant transformants exhibited a decreased accumulation of gentamicin due to the absence of the rapid, energy-dependent phase of uptake. Resistance was not through metabolic inactivation of the antibiotic; no aminoglycoside-acetylating, -adenylylating, or -phosphorylating activity was detected in the wild-type strains or in the 2-DAM-resistant transformants. Protein synthesis in 2-DAM-susceptible H. influenzae strains increased in the presence of low (1 ,ug/ml) and moderate (50 ,ug/ml) concentrations of tobramycin. With higher concentrations (100 and 500 ,ug/ml), protein synthesis was progressively inhibited. In contrast, protein synthesis in 2-DAM-resistant clinical isolates and transformants was inhibited by 1 ,ug of tobramycin per ml, and inhibition increased with higher drug concentrations. Since the stimulating effect of low concentrations of tobramycin in susceptible H. influenzae strains is probably due to misreading, these findings suggest that 2-DAM-resistant strains of H. influenzae have reduced sensitivity to misreading, indicating that altered ribosomes are responsible for the resistance.
Although its pathogenic role has not been defined with certainty, nontypable Haemophilus influenzae can be cultured in high densities from the bronchial secretions of patients with cystic fibrosis (CF) or chronic bronchitis (21, 26, 33, 38) . With the use of selective culture media, this organism frequently can be recovered in the presence of other pathogenic organisms, such as members of the Enterobacteriaceae, Pseudomonas aeruginosa, Streptococcus pneumoniae, and Staphylococcus aureus (33, 45) . When patients with CF harbor P. aeruginosa and H. influenzae in similar densities in their bronchial secretions, the former organism is generally considered the main pathogen, and antimicrobial therapy that is effective against P. aeruginosa (i.e., an antipseudomonal penicillin and a 2-deoxystreptamine aminoglycoside ) is administered. The diffusion of these antibiotics into the bronchial secretions is poor, and their bioactivity in this environment is reduced; antipseudomonal penicillins are inactivated by P-lactamases (15) , and aminoglycosides are bound to DNA from lysed cells (24, 40) and antagonized by the low pH (3) and the ionic content of purulent bronchial secretions (24) . Thus, high densities of H. influenzae in the bronchial secretions may be exposed for prolonged periods to subinhibitory concentrations of We hypothesized that this situation could favor the emergence of resistance. Therefore, we screened 38 strains of H. influenzae that were recently isolated from lower-respiratory-tract specimens for resistance to 2-DAM and identified 6 such strains. Resistance to 2-DAM was also present in two of four strains that were isolated from sputum in New Zealand and were sent to us because of resistance to ampicillin without detectable P-lactamase activity. By contrast, none of 63 strains recently isolated from other body sites was resistant. We characterized the genetic basis and the mechanism of resistance to 2-DAM of selected resistant isolates of H. influenzae. In this paper we present evidence indicating that resistance in these strains is encoded by a chromosomal gene, is not mediated by the production of aminoglycoside-inactivating enzymes, and is associated with reduced antibiotic uptake. We compared the effect of 2-DAM on protein synthesis by susceptible and resistant strains. The use of supernatants derived from 30,000-x -g centrifugation of disrupted bacteria (S30 fractions) as a cell-free protein synthesis system yielded very low incorporation of [14C] valine into trichloroacetic acid (TCA)-precipitable material in H. influenzae. Bacteria made permeable to small macromolecules by brief treatment with ether have been used previously to study DNA and RNA synthesis (18, 41) . We Media. The medium used for growth of H. influenzae was brain heart infusion medium (Difco) supplemented with 10 ,ug of hemin per ml, 10 ,ug of L-histidine per ml, and 10 ,ug of 1-NAD per ml (sBHI). Because of the influence of the ionic content of the culture medium on the antimicrobial activity of aminoglycosides (27) and because of the variability in ionic composition of various batches of broth (43) , all susceptibility testing was performed by using the same lot of brain heart infusion medium (lot 685128). Agarose (0.85%; lot 48G-0011; Sigma Chemical Co., St. Louis, Mo.) was substituted for agar. Nutrient broth (lot 681161; Difco) was used in the gentamicin uptake experiments.
Antibiotics and chemicals. Gentamicin, tobramycin, kanamycin, streptomycin, chloramphenicol, and puromycin were obtained in crystalline form from Sigma Chemical Co.
[14C]gentamicin (specific activity, 789 ,uCi/g) was donated by Transformation to tobramycin resistance. Strains Rd and RdMCR were grown in sBHI to an A675 of 0.4 U, washed in MIV competence medium (20) , and incubated for 100 min at 37°C as previously described (34) . A 2-ml portion of culture was incubated for 30 min with 0.1 ml of cell lysate; 4 ml of sBHI was added, and the cells were allowed to grow for 2 h. At that time, 100-,ul portions of the undiluted culture and of 10-1 and 10-2 dilutions were plated onto sBHI agarose containing 12.5 ,ug of tobramycin per ml. The plates were incubated at 37°C for 72 h and examined for the presence of colonies every 24 h. The phenotype of the colonies was verified by replica plating onto medium containing 12.5 Fag of tobramycin per ml. To examine the frequency of mutation to tobramycin resistance of the recipient strains, competent cells without added DNA were grown in the same fashion and plated onto sBHI containing tobramycin.
Conjugation. Filter matings were performed as described previously (35) . The donor strains, strains C450 and 801107, were mated with strain RdMCR (Smr, Err, Rif), and transconjugants were selected on medium containing 15 [Lg of tobramycin per ml and 10 ,g of erythromycin per ml or 15 ,ug of tobramycin per ml and 10 p.g of rifampin per ml.
Agarose gel electrophoresis. Cleared lysates of bacterial strains were prepared as described by Meyers et al. (28) and were subjected to electrophoresis through a 0.7% agarose gel.
Aminoglycoside-modifying enzymes. Tobramycinacetylating, -adenylylating, or -phosphorylating enzyme assays were performed as described by Davies (11) . The following positive controls were used: E. coli W677/JR66 (37) was used as the source of tobramycin-adenylylating and kanamycin-phosphorylating enzymes; and E. coli C600(pMB8::Tnl700) (36) was used as a source of tobramycin-acetylating enzyme.
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Gentamicin accumulation. Gentamicin uptake was measured as described by Bryan and Van Den Elzen (7).
[14C]gentamicin was used in these experiments. Organisms grown overnight on sBHI agarose were used to inoculate nutrient broth supplemented with 10 ,ug of P-NAD per ml and 10 jig of hemin per ml. A titer of organisms that resulted in an increase in optical density at 420 nm of 0.1 Unit was used in each experiment. The cultures were incubated for 1 h at 37°C in a shaking water bath before 10 jig of [14C]gentamicin per ml was added. Samples (5 ml) were filtered through a 0.2-,um membrane filter (Amicon Corp., Lexington, Mass.) at zero time and after 5, 10, 15, 20, and 30 min. The filters were then washed with 20 ml of 3.5% NaCl and dried. The amount of gentamicin associated with the organisms after the washing procedure was assayed by scintillation spectrometry. To reduce nonspecific binding of gentamicin to the filter membranes, the filters were pretreated with 2.5 ml of a 400-,ug/ml solution of nonradioactive gentamicin. Binding to the filter membrane was measured by assaying the radioactivity present on a filter through which medium containing [14C]gentamicin but no organisms was filtered. All measurements were corrected for nonspecific binding. Before [14C]gentamicin was added to the broth, 1 ml of the bacterial suspension was centrifuged at 12,000 x g for 3 min. The resulting pellet was washed three times in phosphate-buffered saline, and its protein content was assayed by the Folin phenol method (25) . Bacterial counts were performed before addition of gentamicin, at zero time, and at 5, 10, 15, 20, and 30 min by plating 0.1-ml undiluted samples and serial 10-2 dilutions onto sBHI agar. Preliminary experiments showed that lowering the agar pH to 6 or incubating the plates under anaerobic conditions to avoid the carry-over effect of gentamicin did not result in higher bacterial counts.
Preparation of S30 extracts. S30 fractions were prepared as described by Moldolell and Davis (31) . Organisms were grown in 3 liters of sBHI, harvested by centrifugation, and washed once with 60 ml of standard buffer (10 mM Tris chloride, pH 8, 10 mM magnesium acetate, 60 mM ammonium chloride, 6 mM 2-mercaptoethanol). The cell pellet was ground in the cold (4°C) with two times its weight of alumina (type 305; Sigma) for 5 min and extracted with standard buffer (1 ml/g of cells and alumina). Supernatants (30,000 x g) were prepared by two steps of centrifugation, first centrifugation for 10 min at 15,000 x g and then centrifugation for 30 min at 30,000 x g. After the first centrifugation, DNase (2 pg/ml; Worthington) was added to the supernatant. The S30 fractions were dialyzed overnight at 0 to 4°C against 100 volumes of standard buffer, divided into portions, and stored at -70°C until they were used.
Preparation of ether-permeabilized cells. Bacterial cells were treated with ether as described by Vosberg and Hoffman-Berling (41), with slight modifications. Organisms were grown in 300 ml of brain heart infusion broth to mid-log phase, harvested by centrifugation at 4°C, washed with 10 ml of standard buffer, and suspended in 10 ml of the same buffer. The cell suspension was mixed with the same volume of diethyl ether by gentle agitation for 1 min in a glassstoppered tube in the cold (4°C). After the ether and aqueous phases had separated, the ether was removed with a pipette.
The cell suspension was centrifuged at 10,000 x g for 10 min, washed with 5 ml of standard buffer, centrifuged at 10,000 x g for 20 min, suspended in 2 ml of standard buffer, divided into portions, and frozen at -70°C.
In vitro protein synthesis directed by natural mRNA. Protein synthesis was carried out at 37°C for 30 min as described by Davies (11) (9) . We found that strain MAP had the same resistance to 2-DAM as the primary clinical isolates. There was also 100% linkage among kanamycin resistance, tobramycin resistance, and amikacin resistance ( Figure 1 shows the uptake of gentamicin by strain Rd and gentamicinresistant transformant Rd/801107. Two phases of gentamicin uptake, an initial energy-independent phase and a rapid energy-dependent phase, were observed for strain Rd. Gentamicin uptake was reduced by 95% in the presence of 0.1% sodium azide, an electron transport inhibitor. Transformant Rd/801107 showed initial binding, followed by an energydependent phase of uptake that was markedly slower than the energy-dependent phase in the isogenic susceptible strain. Uptake by both strains was the same in the presence of sodium azide. Protein synthesis by S30 fractions. Cell-free protein synthesis systems prepared from strains of H. influenzae by alumina grinding had low activity. Nonpreincubated S30 frac- Protein synthesis by ether-extracted cells. We wanted to determine whether bacteria made permeable to lowmolecular-weight compounds by a brief treatment with ether could be used as a more efficient system to investigate protein synthesis in fastidious organisms, such as H. influenzae. Protein synthesis by ether-treated cells was studied in a reaction mixture similar to that recommended for S30 cell-free extracts (11) . In the presence of amino acids, ATP, and an energy-generating source, ['4C]valine was incorporated into TCA-precipitable material. supply of ATP and amino acids and was almost totally dependent on the addition of an ATP-generating system. (19) can freely penetrate into ether-treated organisms in strains with a characterized permeability barrier, we compared the effects of tobramycin and streptomycin on protein synthesis by S30 supernatants and ether-treated cells of two E. coli K-12 derivatives, strain C600, which is susceptible to all aminoglycosides (36) , and strain AN66, a ubiquinone-deficient mutant which accumulates reduced amounts of tobramycin and streptomycin and has ribosomal resistance to streptomycin (10) . The two methods yielded a similar assessment of the effects of tobramycin and streptomycin on protein synthesis in these two strains; increasing concentrations of tobramycin had the triphasic effect described by Tai and Davis (39) and Zierhut et al. (46) , indicating that the ribosomes of both strains were sensitive. Streptomycin had no effect on protein synthesis in strain AN66, confirming ribosomal resistance, and inhibited protein synthesis in a monophasic fashi3n in strain C600 (data not shown).
The effects of tobramycin on ether-treated susceptible and resistant strains of H. influenzae were also examined. In three susceptible strains of H. influenzae strain (Rd, an untypable laboratory strain used as the recipient in the transformation experiments; strain Ela, a type b strain isolated from cerebrospinal fluid; and strain C1086, an untypable isolate from CF sputum), [14C]valine incorporation remained constant or increased in the presence of tobramycin at concentrations ranging from 1 to 50 ,ug/ml (Fig. 2) . At 100 ,ug/ml protein synthesis was partially inhibited in one of the three strains, and at 500 ,ug/ml protein synthesis was suppressed. In resistant H. influenzae strains (strain 801107, transformant Rd/801107, and strain E12, a spontaneous mutant of strain Ela selected for 2-DAMresistance), inhibition of protein synthesis was detected at a tobramycin concentration of 1 ,ug/ml, with greater inhibition observed as the antibiotic concentration was increased (Fig.  2) . Paired experiments were repeated four times with selected concentrations of tobramycin (1, 50 , and 500 ,ug/ml) for strains Rd and Rd/801107. The difference in incorporation of [14C]valine between the two isogenic organisms was statistically significant for concentrations of 1 and 50 ig/ml (P < 0.01, Student's t test). There was no difference in [14C]valine incorporation at a tobramycin concentration of 500 ,ug/ml (Fig. 3) .
DISCUSSION
The most common mechanism of resistance to 2-DAM in bacteria isolated from patients is plasmid-mediated, enzymatic modification of the antibiotic (2, 14, 30, 32) . The substrate range of the inactivating enzymes is distinctive; various patterns of substrate specificity result in different resistance phenotypes (11) . No single enzyme inactivates all of the aminoglycosides used clinically. However, some organisms harbor plasmids that code for more than one inactivating enzyme, resulting in resistance to multiple aminoglycosides (11) . Studies by Dickie et al. have suggested that enzymatically modified aminoglycosides have a reduced affinity for ribosomes and are unable to interfere with ribosomal protein -synthesis (16) . There is also a decreased accumulation of the antibiotic in these organisms; binding to ribosomes is necessary for the rapid energy-dependent phase of aminoglycoside uptake to occur (6) .
The following three pieces of evidence suggest that in the 2-DAM-resistant strains of H. influenzae which we studied resistance does not occur through antibiotic inactivation of the antibiotic. (i) The gene coding for resistance is located on the chromosome; resistance to aminoglycosides by enzymatic inactivation is not usually encoded by chromosomal genes (14, 22) . (ii) All wild-type organisms, as well as transformants, are resistant to a wide range of 2-DAM antibiotics, including tobramycin, gentamicin, amikacin, sisomicin, and kanamycin; no single acetylating, adenylylating, or phosphorylating enzyme has such a wide substrate range (11) , and thus the presence of more than one enzyme in the resistant strains must be postulated to explain the observed phenotype. (iii) Tobramycin-inactivating enzymes were not detected in wild-type organisms or in 2-DAMresistant transformants.
Bacterial mutants with nonenzymatic resistance to aminoglycosides are due to defective antibiotic transport (5) or to ribosomal resistance (2) . Ribosomal resistance to 2-DAM antibiotics is very infrequent. Single-step, high-level resistance bacterial mutants have not been isolated (19) . However, spontaneous and ethylmethanesulfonate-induced mutants of E. coli with low-level resistance to gentamicin and alteration of 50S ribosome subunit protein L6 have been described previously (8) . As with streptomycin, most of the strains with nonenzymatic resistance to 2-DAM antibiotics exhibit resistance on the basis of reduced intracellular transport (5, 32, 44) .
Streptomycin and gentamicin differ markedly in their interactions with ribosomes and in their effects on protein synthesis. Both compounds act on initiating ribosomes (31, 39, 46) and on ribosomes engaged in chain extension, inhibiting polypeptide chain extension (39, 42) and inducing misreading (12, 13) . For streptomycin, these effects increase in a monophasic way as the concentration of the drug is increased and result in complete blockage of polypeptide initiation or extension (31, 42, 46) . In contrast, increasing the gentamicin concentration affects protein synthesis in a triphasic manner (39, 46) ; at a low concentration (1 peg/ml), gentamicin causes slowing of protein synthesis, but little misreading. At moderate concentrations (about 50 ,ug/ml), synthesis is markedly increased in duration, probably because of misreading of the termination signal. At of H. influenzae that were resistant to 2-DAM antibiotics was reduced in the presence of 1 ,ug of tobramycin per ml; the inhibition of incorporation increased at higher tobramycin concentrations. This pattern was observed in wild-type strains, in transformants selected for tobramycin resistance, and in a spontaneous laboratory-selected mutant.
These data indicate that resistance to 2-DAM in clinical isolates of H. influenzae is associated with an altered response of the ribosomes; the ribosomes of these strains respond only to the inhibitory effects of tobramycin, whereas the main effect of this drug on susceptible strains is apparent misreading. Mobilization of the tobramycin resistance gene by transformation results in transformants that are insensitive to the misreading effect of tobramycin. Kuhberger et are not viable and allow the assessment of macromolecular synthesis in the absence of a barrier to low-molecular-weight compounds. This system has been developed to study DNA synthesis (41) and has more recently been used to study DNA transcription (18) . We 
